Standard of Care IST clinical trials

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

This study looks at a new drug, felzartamab, for Primary Membranous Nephropathy (PMN), a kidney disease. Researchers compare it to an existing treatment, tacrolimus, to see how well it works in reducing protein in urine and improving kidney health.